Vaxcyte Inc. Common Stock vs Unusual Machines Inc. Common Stock — how do they compare? Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B), while Unusual Machines Inc. Common Stock trades at $17.35 (market cap $971.15M). The key difference: Vaxcyte Inc. Common Stock is far larger — about 10.8× Unusual Machines Inc. Common Stock's market cap, and Vaxcyte Inc. Common Stock is trading nearer its 52-week high, Unusual Machines Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Vaxcyte Inc. Common Stock for 0 Days and Unusual Machines Inc. Common Stock for 0 Days on average.
| PCVX | UMAC | |
|---|---|---|
Market Cap | $10.51B | $971.15M |
Volume | 2,644,694 | 3,714,986 |
Sector | Health | Technology |
52-Week High | $73.82 | $34.06 |
52-Week Low | $40.32 | $7.76 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $9.14B | $657.94M |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →Unusual Machines Inc. manufactures and sells drone components and complete drones for consumer, enterprise, and defense markets, operating brands including Fat Shark FPV goggles and the Rotor Riot retail platform, with US-based, NDAA-compliant manufacturing.
Read more on UMAC →